Evidence map›Paper›PMID 30364706›Full record

ReviewWorld journal of gastrointestinal oncology2018

Facing the challenge of venous thromboembolism prevention in patients undergoing major abdominal surgical procedures for gastrointestinal cancer.

Aikaterini Mastoraki, Sotiria Mastoraki, Dimitrios Schizas, Raphael Patras, Nikolaos Krinos, Ioannis S Papanikolaou, Andreas Lazaris, Theodore Liakakos, Nikolaos Arkadopoulos

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastrointestinal oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Aikaterini Mastoraki4 Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 12462, Greece. dr_kamast@yahoo.gr.
Sotiria MastorakiDepartment of Vascular Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 12462, Greece.
Dimitrios Schizas1 Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, Athens 11527, Greece.
Raphael Patras4 Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 12462, Greece.
Nikolaos Krinos4 Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 12462, Greece.
Ioannis S Papanikolaou4 Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 12462, Greece.
Andreas LazarisDepartment of Vascular Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 12462, Greece.
Theodore Liakakos1 Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, Athens 11527, Greece.
Nikolaos Arkadopoulos4 Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 12462, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venous thromboembolism (VTE) refers to a hypercoagulable state that remains an important and preventable factor in the surgical treatment of malignancies. VTE includes two identical entities with regards to deep vein thrombosis and pulmonary embolism. The incidence of VTE after major abdominal interventions for gastro-intestinal, hepato-biliary and pancreatic neoplastic disorders is as high as 25% without prophylaxis. Prophylactic use of classic or low-molecular-weight heparin, anti-Xa factors, antithrombotic stocking, intermittent pneumatic compression devices and early mobilization have been described. Nevertheless, thromboprophylaxis is often discontinued after discharge, although a serious risk may persist long after the initial triggering event, as the coagulation system remains active for at least 14 d post-operatively. The aim of this review is to evaluate the results of the current practice of VTE prevention in cancer patients undergoing major abdominal surgical operations, with special attention to adequately elucidated guidelines and widely accepted protocols. In addition, the recent literature is presented in order to provide an update on the current concepts concerning the surgical management of the disease.

Indexed as

Deep vein thrombosisGastro-intestinal cancerPulmonary embolismThromboprophylaxisVenous thromboembolism

Identifiers

PMID30364706
PMCPMC6198300
OpenAlexW2896441122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.